What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Stroke
- Surgery
The scientist’s investigation covers issues in Stroke, Internal medicine, Cardiology, Perfusion scanning and Surgery.
His studies deal with areas such as Tissue plasminogen activator and Randomized controlled trial as well as Stroke.
Christopher R. Levi works mostly in the field of Internal medicine, limiting it down to topics relating to Gastroenterology and, in certain cases, Genetic variation.
Christopher R. Levi is researching Perfusion scanning as part of the investigation of Perfusion and Radiology.
Christopher R. Levi interconnects Desmoteplase, Nuclear medicine, Angiography, Acute stroke and Penumbra in the investigation of issues within Perfusion.
Christopher R. Levi combines subjects such as Transcranial Doppler, Vascular dementia and Normal pressure hydrocephalus with his study of Surgery.
His most cited work include:
- Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial. (865 citations)
- A randomized trial of tenecteplase versus alteplase for acute ischemic stroke. (366 citations)
- Genetic risk factors for ischaemic stroke and its subtypes (the METASTROKE collaboration): a meta-analysis of genome-wide association studies. (353 citations)
What are the main themes of his work throughout his whole career to date?
Stroke, Internal medicine, Cardiology, Thrombolysis and Surgery are his primary areas of study.
His Stroke research includes elements of Randomized controlled trial, Perfusion, Perfusion scanning and Emergency medicine.
The various areas that he examines in his Perfusion scanning study include Infarction, Cerebral blood flow and Penumbra.
When carried out as part of a general Internal medicine research project, his work on Tissue plasminogen activator, Odds ratio, Brain ischemia and Prospective cohort study is frequently linked to work in Genome-wide association study, therefore connecting diverse disciplines of study.
His research in Cardiology intersects with topics in Cerebral infarction and Acute ischemic stroke.
The Thrombolysis study combines topics in areas such as Reperfusion therapy, Anesthesia, Fibrinolytic agent and Acute stroke.
He most often published in these fields:
- Stroke (71.97%)
- Internal medicine (41.48%)
- Cardiology (30.49%)
What were the highlights of his more recent work (between 2018-2021)?
- Stroke (71.97%)
- Internal medicine (41.48%)
- Thrombolysis (27.46%)
In recent papers he was focusing on the following fields of study:
Christopher R. Levi mainly focuses on Stroke, Internal medicine, Thrombolysis, Cardiology and Modified Rankin Scale.
His Stroke research includes elements of Odds ratio, Randomized controlled trial, Perfusion scanning and Emergency medicine.
The study incorporates disciplines such as Diabetes mellitus and Oncology in addition to Internal medicine.
He has researched Thrombolysis in several fields, including Reperfusion therapy, Interquartile range, Blood pressure, Cluster randomised controlled trial and Fibrinolytic agent.
His biological study spans a wide range of topics, including Confounding, Neurology and Cohort.
His Modified Rankin Scale research is multidisciplinary, incorporating perspectives in Occlusion, Brain ischemia and Asymptomatic.
Between 2018 and 2021, his most popular works were:
- Extending thrombolysis to 4·5–9 h and wake-up stroke using perfusion imaging: a systematic review and meta-analysis of individual patient data (123 citations)
- Penumbral imaging and functional outcome in patients with anterior circulation ischaemic stroke treated with endovascular thrombectomy versus medical therapy: a meta-analysis of individual patient-level data (100 citations)
- Intensive blood pressure reduction with intravenous thrombolysis therapy for acute ischaemic stroke (ENCHANTED): an international, randomised, open-label, blinded-endpoint, phase 3 trial (73 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Stroke
- Surgery
Christopher R. Levi mainly investigates Stroke, Internal medicine, Modified Rankin Scale, Randomized controlled trial and Thrombolysis.
His research in Stroke is mostly concerned with Fibrinolytic agent.
His Internal medicine research integrates issues from Oncology and Cardiology.
Christopher R. Levi interconnects Meta-analysis, Occlusion and Brain ischemia in the investigation of issues within Modified Rankin Scale.
His study in Randomized controlled trial is interdisciplinary in nature, drawing from both Anesthesia, Clinical trial and Dissection.
In his study, Perfusion is inextricably linked to Placebo, which falls within the broad field of Odds ratio.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
